Inside the First Cannabis Company to List on Nasdaq

Cronos Group started trading on the Nasdaq Tuesday. The vertically integrated company became the first marijuana company to join a major exchange in the United States. The company's CEO Mike Gorenstein explains how Cronos is capitalizing on the emerging market in Canada. "Entering the U.S. market is really big for us," said Gorenstein. "It continues to show the acceptance the Cannabis industry is getting, and the recognition of how important Cannabis can be." Cronos Group fully owns two subsidiary companies Peace Naturals and Original BC (OGBC), with partial stake in Whistler Medical Marijuana Company.

More In Business

Scaling Prefab with AI: Dextall CEO Aurimas Sabulis Tackles Housing Crisis

Aurimas Sabulis, CEO of Dextall, unveils how AI‑driven prefabricated façades slash design time by 80%, labor by 87%, and accelerate affordable housing delivery.

Home Prices Continue to Rise Despite Declining Sales

U.S. home sales slowed to their weakest pace in nearly 14 years, with rising mortgage rates and affordability concerns affecting market activity.

Jobs Report Underwhelms as Job Growth Stalls

Mark Hamrick of Bankrate helps make sense of the jobs report despite inflation but warns that uncertainty around tariffs could disrupt growth.

Star Trek plans Lego sets for the franchise’s 60th anniversary

Not many franchises have fueled society’s timeless fascination with the boundless possibilities of a utopian future like “Star Trek.”

Robinhood joins new band of companies calling the S&P 500 their home

Online broker Robinhood Markets will join the S&P 500 index Online broker Robinhood Markets will join the S&P 500 index as its stock rides higher on a cryptocurrency wave.

How you too can become a Hollywood insider at a test screening

Anyone can sign up to attend a test screening before a movie is completed.

Big Business This Week: Why does the Fed’s independence matter?

Trump wants interest rates to plummet to make borrowing cheaper and boost growth. Fed chair Jerome Powell and his allies say not so fast, they need to bala

LSD shows promise for reducing anxiety in drugmaker’s midstage study

A midstage study of the psychedelic drug LSD showed positive results for easing symptoms in people with generalized anxiety disorder.

Crunch Fitness President On Navigating Fitness with AI and the GLP‑1 Revolution

Crunch Fitness President Chequan Lewis talks how gyms are adapting to GLP‑1 weight‑loss drugs, integrating AI-powered workouts and embracing new fitness trends.

BetMGM’s Bold Playbook: CEO on Betting Season, App Upgrades & Industry Expansion

Adam Greenblatt, BetMGM CEO, shares insights on football betting forecasts, the booming sports wagering industry, and the game‑changing enhancements to the app.

Load More